CAMP Continuation Study/Phase 2 (CAMPCS/2)

CAMP 继续研究/第 2 阶段 (CAMPCS/2)

• 批准号: 6935209
• 负责人: GAIL G SHAPIRO
• 金额: $ 26.15万
• 依托单位: ASTHMA, INC.
• 依托单位国家: 美国
• 财政年份: 2003
• 资助国家: 美国
• 起止时间: 2003-09-30 至 2007-06-30
• 项目状态: 已结题
• 来源: https://reporter.nih.gov/project-details/6935209
• 关键词: adolescence (12-20); asthma; body height; child physical development; clinical research; cooperative study; corticosteroids; drug adverse effect; human subject; longitudinal human study; lung development; patient care management; respiratory disorder epidemiology; young adult human (21-34)

This application is for ASTHMA, Inc. Research Center to participate in the Childhood Asthma Management Program Continuation Study/Phase 2 (CAMPCS/2). We have succeeded in continuing to follow the CAMPCS protocol by collecting data of high quality, while providing safe and efficient patient care. Seattle enrolled 144 patients in CAMP and 127 of these patients have enrolled in CAMPCS. In addition, two pilot patients continue in CAMPCS. Of the patients who completed transition in CAMP, 98% continued on in CAMPCS..Seattle CAMPCS investigators and staff will continue to support the continuation of follow up of CAMP patients through CAMPCS/2. The families and patients of CAMPCS continue to be committed to the study and we anticipate their continued involvement through CAMPCS/2. The abstract and research plan for CAMPCS/2 is included in the application from the Washington University (Robert Strunk, PI).

此申请适用于 ASTHMA, Inc. 研究中心参与儿童哮喘项目 管理计划继续研究/第二阶段 (CAMPCS/2)。 我们成功地继续遵循 CAMPCS 协议，收集高质量的数据，同时提供安全高效的患者护理。西雅图在 CAMP 中登记了 144 名患者，其中 127 名患者已在 CAMPCS 中登记。此外，两名试点患者继续接受 CAMPCS 治疗。在完成 CAMP 过渡的患者中，98% 继续接受 CAMPCS。西雅图 CAMPCS 的研究人员和工作人员将继续支持通过 CAMPCS/2 对 CAMP 患者进行继续随访。 CAMPCS 的家属和患者将继续致力于这项研究，我们预计他们将通过 CAMPCS/2 继续参与。 CAMPCS/2的摘要和研究计划包含在华盛顿大学的申请中 大学（罗伯特·斯特伦克，PI）。